PCRX
Price
$31.49
Change
+$1.41 (+4.69%)
Updated
May 16, 6:59 PM EST
76 days until earnings call
SNDL
Price
$2.65
Change
+$0.08 (+3.11%)
Updated
May 16, 6:59 PM EST
90 days until earnings call
Ad is loading...

PCRX vs SNDL

Header iconPCRX vs SNDL Comparison
Open Charts PCRX vs SNDLBanner chart's image
Pacira BioSciences
Price$31.49
Change+$1.41 (+4.69%)
Volume$526.44K
CapitalizationN/A
SNDL
Price$2.65
Change+$0.08 (+3.11%)
Volume$6.64M
CapitalizationN/A
View a ticker or compare two or three
PCRX vs SNDL Comparison Chart

Loading...

PCRXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SNDLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
PCRX vs. SNDL commentary
May 17, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCRX is a Hold and SNDL is a Hold.

COMPARISON
Comparison
May 17, 2024
Stock price -- (PCRX: $30.08 vs. SNDL: $2.57)
Brand notoriety: PCRX and SNDL are both not notable
PCRX represents the Pharmaceuticals: Other, while SNDL is part of the Beverages: Alcoholic industry
Current volume relative to the 65-day Moving Average: PCRX: 101% vs. SNDL: 88%
Market capitalization -- PCRX: $1.36B vs. SNDL: $527.48M
PCRX [@Pharmaceuticals: Other] is valued at $1.36B. SNDL’s [@Beverages: Alcoholic] market capitalization is $527.48M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The market cap for tickers in the [@Beverages: Alcoholic] industry ranges from $19.33T to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $2.9B. The average market capitalization across the [@Beverages: Alcoholic] industry is $19.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PCRX’s FA Score shows that 0 FA rating(s) are green whileSNDL’s FA Score has 0 green FA rating(s).

  • PCRX’s FA Score: 0 green, 5 red.
  • SNDL’s FA Score: 0 green, 5 red.
According to our system of comparison, SNDL is a better buy in the long-term than PCRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PCRX’s TA Score shows that 5 TA indicator(s) are bullish while SNDL’s TA Score has 5 bullish TA indicator(s).

  • PCRX’s TA Score: 5 bullish, 5 bearish.
  • SNDL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SNDL is a better buy in the short-term than PCRX.

Price Growth

PCRX (@Pharmaceuticals: Other) experienced а +1.45% price change this week, while SNDL (@Beverages: Alcoholic) price change was +4.47% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.14%. For the same industry, the average monthly price growth was +37.19%, and the average quarterly price growth was +19330.38%.

The average weekly price growth across all stocks in the @Beverages: Alcoholic industry was +3.53%. For the same industry, the average monthly price growth was +6.89%, and the average quarterly price growth was +3.50%.

Reported Earning Dates

PCRX is expected to report earnings on Jul 31, 2024.

SNDL is expected to report earnings on Aug 14, 2024.

Industries' Descriptions

@Pharmaceuticals: Other (+1.14% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Beverages: Alcoholic (+3.53% weekly)

The alcoholic beverage market includes beer, wine, and spirits. From $230 billion in 2015, the industry has grown to around $250 billion by 2019. In recent years, alcoholic beverage makers have been looking to expand distribution and purchase channels, such as through online stores (e.g. e-commerce platform Drizly) and convenience stores. Anheuser-Busch In Bev and Diageo are major global alcoholic beverage companies, while U.S.-owned companies include Constellation Brands and Brown-Forman Corp. among several others.

SUMMARIES
A.I.dvisor published
a Summary for PCRX with price predictions.
OPEN
A.I.dvisor published
a Summary for SNDL with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
PCRX($1.36B) has a higher market cap than SNDL($527M). PCRX has higher P/E ratio than SNDL: PCRX (32.74) vs SNDL (3.54). SNDL YTD gains are higher at: 56.707 vs. PCRX (-10.848). PCRX has higher annual earnings (EBITDA): 155M vs. SNDL (-99.15M). PCRX has more cash in the bank: 279M vs. SNDL (202M). SNDL has less debt than PCRX: SNDL (167M) vs PCRX (586M). SNDL has higher revenues than PCRX: SNDL (909M) vs PCRX (675M).
PCRXSNDLPCRX / SNDL
Capitalization1.36B527M257%
EBITDA155M-99.15M-156%
Gain YTD-10.84856.707-19%
P/E Ratio32.743.54926%
Revenue675M909M74%
Total Cash279M202M138%
Total Debt586M167M351%
FUNDAMENTALS RATINGS
PCRX: Fundamental Ratings
PCRX
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
84
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PCRXSNDL
RSI
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 11 days ago
79%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Ad is loading...
PCRXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SNDLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TNSIX13.860.28
+2.06%
Touchstone International Growth Ins
FGKFX26.640.47
+1.80%
Fidelity Growth Company K6
CSRYX35.960.26
+0.73%
Columbia Select Large Cap Value Inst3
HWSZX79.670.21
+0.26%
Hotchkis & Wiley Small Cap Value Z
ECOAX9.68N/A
N/A
Ecofin Global Renewables Infras A

PCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCRX has been loosely correlated with ELAN. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if PCRX jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCRX
1D Price
Change %
PCRX100%
-2.40%
ELAN - PCRX
40%
Loosely correlated
-0.18%
TEVA - PCRX
37%
Loosely correlated
-1.81%
ACET - PCRX
27%
Poorly correlated
+5.26%
SNDL - PCRX
26%
Poorly correlated
-1.91%
PAHC - PCRX
25%
Poorly correlated
+0.22%
More

SNDL and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDL has been closely correlated with CGC. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if SNDL jumps, then CGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDL
1D Price
Change %
SNDL100%
-1.91%
CGC - SNDL
77%
Closely correlated
+2.16%
TLRY - SNDL
76%
Closely correlated
-0.96%
CRON - SNDL
73%
Closely correlated
-1.02%
OGI - SNDL
68%
Closely correlated
+5.18%
ACB - SNDL
65%
Loosely correlated
+1.71%
More